Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 31, Issue 6, 2016, Pages 1141-1146

  Njei, Basile ^a   Mccarty, Thomas R ^a   Birk, John W ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Adenocarcinoma; Carcinoma; Esophagus; Squamous

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; FEMALE; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; SURVIVAL RATE; UNITED STATES; VERY ELDERLY; ADENOCARCINOMA; AGE; CANCER STAGING; CARCINOMA, SQUAMOUS CELL; COMPARATIVE STUDY; EARLY CANCER DIAGNOSIS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS RESECTION; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; TRENDS;

ADENOCARCINOMA; AGE FACTORS; AGED; CARCINOMA, SQUAMOUS CELL; EARLY DETECTION OF CANCER; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEER PROGRAM; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84971350845     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.13289     Document Type: Article

References (41)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J. Clin. 2015; 65: 5-29.
2. Simard EP, Ward EM, Siegel R, Jemal A. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J. Clin. 2012; 62: 118-28.
3. Hansson LE, Sparen P, Nyren O. Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden. Int. J. Cancer 1993; 54: 402-7.
4. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin. 2011; 61: 69-90.
5. Engel LS, Chow WH, Vaughan TL et al. Population attributable risks of esophageal and gastric cancers. J. Natl. Cancer Inst. 2003; 95: 1404-13.
6. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287-9.
7. Bollschweiler E, Wolfgarten E, Gutschow C, Holscher AH. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001; 92: 549-55.
8. Dubecz A, Gall I, Solymosi N et al. Temporal trends in long-term survival and cure rates in esophageal cancer: a SEER database analysis. J. Thorac. Oncol. 2012; 7: 443-7.
9. Cen P, Banki F, Cheng L et al. Changes in age, stage distribution, and survival of patients with esophageal adenocarcinoma over three decades in the United States. Ann. Surg. Oncol. 2012; 19: 1685-91.
10. Hur C, Miller M, Kong CY et al. Trends in esophageal adenocarcinoma incidence and mortality. Cancer 2013; 119: 1149-58.
11. Pohl H, Sirovich B, Welch HG. Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol. Biomarkers Prev.: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010; 19: 1468-70.
12. Trivers KF, Sabatino SA, Stewart SL. Trends in esophageal cancer incidence by histology, United States, 1998-2003. Int. J. Cancer 2008; 123: 1422-8.
13. Polednak AP. Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas. Int. J. Cancer 2003; 105: 98-100.
14. Nordenstedt H, El-Serag H. The influence of age, sex, and race on the incidence of esophageal cancer in the United States (1992-2006). Scand. J. Gastroenterol. 2011; 46: 597-602.
15. Fritz A, Percy C, Jack A et al., eds. International Classification of Diseases for Oncology, 3rd edn. Geneva: World Health Organization, 2000.
16. Percy C, Van Holten V, Muir C, eds. International Classification of Diseases for Oncology, 2nd edn. Geneva: World Health Organization, 1990.
17. World Health Organization G. International classification of diseases for oncology, 3rd edn. 2000.
18. Agresti A. Introduction to categorical data analysis. New York: Wiley, 1996; 182-5 7-9, 201, 17, 79.
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958; 53: 457-81.
20. Mariette C, Piessen G, Triboulet JP. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol. 2007; 8: 545-53.
21. Wang KK, Sampliner RE, Practice Parameters Committee of the American College of G. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am. J. Gastroenterol. 2008; 103: 788-97.
22. Wolf MC, Stahl M, Krause BJ et al. Curative treatment of oesophageal carcinoma: current options and future developments. Radiat. Oncol. 2011; 6: 6-55.
23. Hofstetter W, Swisher SG, Correa AM et al. Treatment outcomes of resected esophageal cancer. Ann. Surg. 2002; 236: 376-84; discussion 84-5.
24. Kohn GP, Galanko JA, Meyers MO, Feins RH, Farrell TM. National trends in esophageal surgery-are outcomes as good as we believe? J. Gastrointest. Surg.: official journal of the Society for Surgery of the Alimentary Tract 2009; 13: 1900-10; discussion 10-2.
25. Falk GW, Ours TM, Richter JE. Practice patterns for surveillance of Barrett's esophagus in the United States. Gastrointest. Endosc. 2000; 52: 197-203.
26. Lagergren J. Any role for endoscopy screening or surveillance for esophageal adenocarcinoma among persons with GERD? Gastrointest. Endosc. 2008; 68: 856-8.
27. Cameron AJ, Lomboy CT, Pera M, Carpenter HA. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995; 109: 1541-6.
28. Fortner JG, Klimstra DS, Senie RT, Maclean BJ. Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy. Ann. Surg. 1996; 223: 147-53.
29. Roayaie S, Jibara G, Taouli B, Schwartz M. Resection of hepatocellular carcinoma with macroscopic vascular invasion. Ann. Surg. Oncol. 2013; 20: 3754-60.
30. Garidou A, Tzonou A, Lipworth L, Signorello LB, Kalapothaki V, Trichopoulos D. Life-style factors and medical conditions in relation to esophageal cancer by histologic type in a low-risk population. Int. J. Cancer 1996; 68: 295-9.
31. Vaughan TL, Davis S, Kristal A, Thomas DB. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev.: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1995; 4: 85-92.
32. Enzinger PC, Mayer RJ. Esophageal cancer. N. Engl. J. Med. 2003; 349: 2241-52.
33. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 2049-53.
34. Chang DT, Chapman C, Shen J, Su Z, Koong AC. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis. Am. J. Clin. Oncol. 2009; 32: 405-10.
35. Bedenne L, Michel P, Bouche O et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J. Clin. Oncol. 2007; 25: 1160-8.
36. Shaheen NJ. Advances in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology 2005; 128: 1554-66.
37. El-Serag HB, Mason AC, Key C. Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology 2001; 33: 62-5.
38. Moyer LA, Boyle CA, Pollock DA. Validity of death certificates for injury-related causes of death. Am. J. Epidemiol. 1989; 130: 1024-32.
39. Nathan H, Pawlik TM. Limitations of claims and registry data in surgical oncology research. Ann. Surg. Oncol. 2008; 15: 415-23.
40. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med. Care 2002; 40: IV-3-18.
41. Cooper GS, Virnig B, Klabunde CN, Schussler N, Freeman J, Warren JL. Use of SEER-Medicare data for measuring cancer surgery. Med. Care 2002; 40: IV-43-8.